Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022 ...

Abstract Background This study assessed seroprevalence trends of SARS-CoV-2 antibodies in the Belgian adult population between March 2021 and April 2022, and explored factors associated with seropositivity and seroreversion among the vaccinated and unvaccinated population. Methods A prospective longitudinal surveillance study was conducted within a random sample of the general population (18 + years) in Belgium, selected from the national register through a multistage sampling design. Participants provided a saliva sample and completed a survey questionnaire on three occasions: at baseline and... Mehr ...

Verfasser: Van der Heyden, Johan
Leclercq, Victoria
Duysburgh, Els
Cornelissen, Laura
Desombere, Isabelle
Roukaerts, Inge
Gisle, Lydia
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2024
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Microbiology / FOS: Biological sciences / Biotechnology / Ecology / Immunology / FOS: Clinical medicine / Biological Sciences not elsewhere classified / Science Policy / Infectious Diseases / FOS: Health sciences / Computational Biology
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28971006
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.7236633.v1

Abstract Background This study assessed seroprevalence trends of SARS-CoV-2 antibodies in the Belgian adult population between March 2021 and April 2022, and explored factors associated with seropositivity and seroreversion among the vaccinated and unvaccinated population. Methods A prospective longitudinal surveillance study was conducted within a random sample of the general population (18 + years) in Belgium, selected from the national register through a multistage sampling design. Participants provided a saliva sample and completed a survey questionnaire on three occasions: at baseline and in two follow-up waves. Outcome variables included (1) seropositivity, defined as the presence of SARS-CoV-2 antibodies, assessed with a semi-quantitative measure of anti-RBD (Receptor Binding Domain) IgG ELISA and (2) seroreversion, defined as passing from a positive to a negative antibody test between two measurements. Trends in SARS-CoV-2 antibody prevalence were assessed using binary logistic regression with ...